Abstract
Targeting the TIE2 pathway with a novel small molecule vascular endothelial protein tyrosine phosphatase (VE-PTP) inhibitor in high-grade serous ovarian cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have